240 related articles for article (PubMed ID: 28608529)
1. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
Whittle RM; Denney H; Chantry AD; Alfred A; Taylor PC
J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
3. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
Afzal A; Tarbunova M; Despotis G; Grossman BJ
Transfusion; 2020 Feb; 60(2):351-357. PubMed ID: 31919871
[TBL] [Abstract][Full Text] [Related]
4. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
8. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.
Rangarajan HG; Punzalan RC; Camitta BM; Talano JA
Br J Haematol; 2013 Nov; 163(3):357-64. PubMed ID: 23961954
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
10. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients.
Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287
[TBL] [Abstract][Full Text] [Related]
11. Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC
J Clin Apher; 2021 Feb; 36(1):34-40. PubMed ID: 32894888
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
13. Safety and collection efficiency with a lower transfusion threshold for extracorporeal photopheresis in adult patients with graft-versus-host disease.
Liu C; Schindler E; LeRoy M; Martin-Bredahl K; Dino M; Shah K; Dynis M; Eby CS; Grossman BJ
Vox Sang; 2017 May; 112(4):379-387. PubMed ID: 28271523
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
[TBL] [Abstract][Full Text] [Related]
15. CD209
Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease.
Oarbeascoa G; Lozano ML; Guerra LM; Amunarriz C; Saavedra CA; Garcia-Gala JM; Viejo A; Revilla N; Acosta Fleitas C; Arroyo JL; Martinez Revuelta E; Galego A; Hernandez-Maraver D; Kwon M; Diez-Martin JL; Pascual C;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):651-658. PubMed ID: 31917270
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
19. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
20. A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease.
Kitko CL; Abdel-Azim H; Carpenter PA; Dalle JH; Diaz-de-Heredia C; Gaspari S; Gennery AR; Handgretinger R; Lawitschka A
Transplant Cell Ther; 2022 May; 28(5):261.e1-261.e7. PubMed ID: 35124293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
